as 07-24-2024 9:38am EST
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.
Founded: | 2006 | Country: | United States |
Employees: | N/A | City: | DURHAM |
Market Cap: | 92.6M | IPO Year: | N/A |
Target Price: | $0.35 | AVG Volume (30 days): | 1.7M |
Analyst Decision: | Hold | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.30 | EPS Growth: | N/A |
52 Week Low/High: | $0.20 - $0.40 | Next Earning Date: | 08-08-2024 |
Revenue: | $8,724,000 | Revenue Growth: | 24.68% |
Revenue Growth (this year): | 43.43% | Revenue Growth (next year): | 81.68% |
ASXC Breaking Stock News: Dive into ASXC Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
GlobeNewswire
11 days ago
GlobeNewswire
a month ago
The Telegraph
2 months ago
Simply Wall St.
2 months ago
Simply Wall St.
2 months ago
Simply Wall St.
2 months ago
Motley Fool
2 months ago
The information presented on this page, "ASXC Asensus Surgical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.